Clinigen and ORPHELIA Pharma sign an exclusive supply agreement

LONDON: Clinigen Group plc), the global pharmaceutical Products and Services company, and ORPHELIA Pharma, a pharmaceutical company specialised in orphan and paediatric medicines, announce that they have signed an exclusive agreement to manage the supply and distribution of Kigabeq® into unlicensed markets.

 

Kigabeq® was granted a European Paediatric Use Marketing Authorization (PUMA) in September 2018 and is currently approved for the treatment of infantile spasms (West Syndrome) and pharmaco-resistant focal-onset seizures (partial seizures).

 

Under the terms of the agreement, Clinigen will provide access to Kigabeq® 500 mg and 100 mg soluble tablets into markets where Kigabeq® is not commercially available. Clinigen will manage all elements of the supply including healthcare practitioner enquiry management, regulatory oversight, logistics and access management. The agreement currently covers all global territories except for USA, China, EU, UK and Bangladesh.

 

Sam Herbert, Chief Operating Officer and Head of Products Division, Clinigen, said: “We are pleased to be partnering with ORPHELIA Pharma and to be supplying Kigabeq® through our product lifecycle platform.  This agreement will offer healthcare professionals another option to treat difficult-to-manage types of epilepsy. This is a great example of how Clinigen’s lifecycle platform can help patients gain access to medicines which are not otherwise available.”

 

Hugues Bienaymé, General Manager of ORPHELIA Pharma added:

We are delighted to have entered into this collaboration with Clinigen. With this agreement, our ambition to make Kigabeq® available worldwide, will be fulfilled.”

 

Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • RSS Newsnreleases

    • Shell, Uber and Muawin collaborate for innovative fuel management solutions 29-Jul-2021
      KARACHI, PAKISTAN: Shell Pakistan Limited collaborated with Uber and Muawin by Cashew Financial Services, to deliver a fuel management solution with... Continue reading The post Shell, Uber and Muawin collaborate for innovative fuel management solutions appeared first on NewsnReleases.
    • TotalEnergies exits from Petrocedeño 29-Jul-2021
      PARIS, FRANCE: TotalEnergies, through its affiliate Total Venezuela, has decided to transfer its non-operated minority participation of 30.32% in Petrocedeño... Continue reading The post TotalEnergies exits from Petrocedeño appeared first on NewsnReleases.
    • TotalEnergies to power Amazon’s operations with renewables 29-Jul-2021
      PARIS, FRANCE: TotalEnergies has announced a strategic collaboration with Amazon through which TotalEnergies will contribute to Amazon’s commitment to power... Continue reading The post TotalEnergies to power Amazon’s operations with renewables appeared first on NewsnReleases.
    • Raymond James agrees to acquire Charles Stanley Group for £278.9 million 29-Jul-2021
      LONDON, UK: Raymond James UK Wealth Management Holdings Limited (Bidco) has agreed to buy entire issued and to be issued... Continue reading The post Raymond James agrees to acquire Charles Stanley Group for £278.9 million appeared first on NewsnReleases.
    • ESO Investments acquires majority stake in Hamsard 3634 29-Jul-2021
      LONDON, UK: EPE Special Opportunities Limited (ESO) through ESO Investments 1 Limited acquired a majority stake in Hamsard 3634 Limited,... Continue reading The post ESO Investments acquires majority stake in Hamsard 3634 appeared first on NewsnReleases.